Nothing is charged here. Payment follows once your place is accepted.
Your pass
Enduser
Supplier
Academic
Pop-Up
Partner
One seat for an end user principal, across both days. A year's membership of the Circle is included.
One seat for a supplier, across both days. A year's membership of the Circle is included.
One seat for a university or research institute, across both days.
Presence. Entry and pop up presence for one forum, across both days, with your name among the forum's partners.
Voice, Curated or Floor. By contract and invoice. The team will write to you directly.
The price, and the link to settle it, come with your welcome note once your place is accepted. VAT at 20% is added for a UK billing address.
How you would pay
Card
Invoice and bank transfer
Optional. For an office that registers a leader, and for an invoice that must carry a purchase order.
Three questions. Shapes who you sit with and what we prepare.
Current challenges
Select up to two
Target identification and validation
Lead optimisation and the design, make, test cycle
Translational models and new approach methods
AI and machine learning in discovery decisions
Data quality, curation and sharing
Accountability when a model is wrong
CRO and partner management
Other
Current investment areas
Select up to two
AI and computational discovery
Automation and closed loop labs
Translational models and new approach methods
Data platforms and shared data
Design, make, test capacity
External partnerships and CROs
Other
Which digital or AI technologies are you actively evaluating or deploying in drug discovery?
Select up to two
Foundation and generative models
Federated learning and shared data
Closed loop and autonomous labs
Digital twin and in silico models
Lab informatics and electronic notebooks
Cloud and high performance computing
None currently active
Where is your organisation's primary focus in discovery over the next 12 months?
Select one
Hit finding and design
Lead optimisation
ADMET and safety prediction
Translational models
Data platform consolidation
Partner and CRO sourcing
Portfolio decision making
What best describes your organisation's current investment posture in drug discovery technology?
Select one
Active procurement · decision within 6 months
Pilot and evaluation stage
Horizon planning · 12-24 months
Strategic review · no immediate mandate
Investment pause · reassessing priorities
What is your typical annual budget influence for technology, equipment and process investments?
Influence means decision authority or material input · not direct control alone
Up to £1M
£1M to £10M
£10M to £100M
£100M to £1B+
Prefer not to disclose